ZMapp Ebola drug stock finished

Washington - The supply of the experimental drug ZMapp used to treat people with the Ebola virus has been exhausted, the US company that makes the medication said on Monday.

"We have complied with every request for ZMapp that had the necessary legal/regulatory authorisation," Mapp Biopharmaceuticals said in a statement.

The company declined to say where the drug has been sent, but said in all cases it was provided at no cost.